107 results
8-K
EX-10.1
7l08zbz5zmqwiajlk48
6 Mar 24
Vaxart, Inc. Appoints Steven Lo as New President, Chief Executive Officer, and Director
9:23am
8-K
EX-10.1
yhnb5i0gby0t3vzmovha
29 Feb 24
Departure of Directors or Certain Officers
4:30pm
8-K/A
EX-10.1
i9g2h 2q28fw9uydx8u
2 Feb 24
Departure of Directors or Certain Officers
4:49pm
8-K
EX-10.1
ctn olm3vtk
16 Jan 24
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
5:18pm
8-K
EX-3.1
jdowwrmu
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
5:01pm
8-K
EX-1.1
f945c
8 Jun 23
Vaxart, Inc. Announces Proposed Public Offering of Common Stock
4:27pm
8-K
xe09k 6r4g8r15b0k
6 Dec 22
Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers
4:21pm
8-K/A
EX-10.1
f210zr15i9o
5 Aug 22
Vaxart Stockholders Approve Proxy Proposals 2, 3 and 4
8:02am
8-K
9d579 6f8kg
28 Jul 22
Other Events
8:00am